AbbVie
ABBV
#27
Rank
โ‚น36.119 T
Marketcap
โ‚น20,437
Share price
1.17%
Change (1 day)
30.70%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น340.53 Billion a decrease over its 2023 earnings that were of โ‚น572.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-57.73%
2024 โ‚น340.53 B-40.54%
2023 โ‚น572.75 B-53.62%
2022 โ‚น1.235 T3.76%
2021 โ‚น1.190 T282.25%
2020 โ‚น311.39 B-59.67%
2019 โ‚น772.16 B62.13%
2018 โ‚น476.25 B-32.74%
2017 โ‚น708.10 B-1.99%
2016 โ‚น722.49 B18.65%
2015 โ‚น608.95 B180.5%
2014 โ‚น217.09 B-55.57%
2013 โ‚น488.62 B-6.86%
2012 โ‚น524.63 B56.05%
2011 โ‚น336.18 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.086 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.062 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น755.48 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น174.48 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น905.96 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น736.15 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.199 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น854.35 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น53.44 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA